| Literature DB >> 7970731 |
I A Wadman1, H L Hsu, M H Cobb, R Baer.
Abstract
Alteration of the TAL1 gene is the most common genetic lesion found in patients with T cell acute lymphoblastic leukemia. TAL1 encodes a basic helix-loop-helix transcription factor that is phosphorylated on serine residue 122 by the mitogen-activated protein (MAP) kinase ERK1. Here we show that the amino-terminal sequences of TAL1 (residues 1-166) function in vivo as a transcriptional activation domain. Mutation of serine residue 122 reduces the potency of the transactivation domain by more than half. The data suggest that the amino-terminal transactivation domain of TAL1 is positively regulated by S122 phosphorylation and that the functional properties of TAL1 can be influenced by signal transduction pathways that involve the MAP kinases.Entities:
Mesh:
Substances:
Year: 1994 PMID: 7970731
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867